Stocks & Investing
Thu, May 16, 2024
[ Thu, May 16th 2024
] - WOPRAI
Thu, April 11, 2024
[ Thu, Apr 11th 2024
] - WOPRAI
Tue, March 26, 2024
[ Tue, Mar 26th 2024
] - WOPRAI
Fri, March 15, 2024
[ Fri, Mar 15th 2024
] - WOPRAI
Tue, November 21, 2023
[ Tue, Nov 21st 2023
] - WOPRAI
Thu, August 10, 2023
[ Thu, Aug 10th 2023
] - WOPRAI
Mon, June 26, 2023
[ Mon, Jun 26th 2023
] - WOPRAI
Tue, May 16, 2023
[ Tue, May 16th 2023
] - WOPRAI
Wed, March 29, 2023
[ Wed, Mar 29th 2023
] - WOPRAI
Wed, November 16, 2022
[ Wed, Nov 16th 2022
] - WOPRAI
Fri, June 3, 2022
[ Fri, Jun 03rd 2022
] - WOPRAI
Tue, May 18, 2021
[ Tue, May 18th 2021
] - WOPRAI
[ Tue, May 18th 2021
] - WOPRAI
Justin Zelin Initiated (TCRX) at Strong Buy and Held Target at $12 on, May 16th, 2024
Justin Zelin of BTIG, Initiated "TScan Therapeutics, Inc." (TCRX) at Strong Buy and Held Target at $12 on, May 16th, 2024.
Justin has made no other calls on TCRX in the last 4 months.
There are 4 other peers that have a rating on TCRX. Out of the 4 peers that are also analyzing TCRX, 0 agree with Justin's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Justin
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Tuesday, May 14th, 2024
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $11 on, Monday, May 13th, 2024
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $10 on, Tuesday, April 23rd, 2024
- Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $9 on, Thursday, March 7th, 2024
